Metformin: evidence-based versus rational pharmacotherapy.
作者信息
Smits P, Tack C J J
出版信息
Neth J Med. 2002 Jul;60(6):228-30.
PMID:12365465
Abstract
摘要
相似文献
1
Metformin: evidence-based versus rational pharmacotherapy.
Neth J Med. 2002 Jul;60(6):228-30.
2
Metformin: diamonds are forever.
Expert Opin Pharmacother. 2009 Oct;10(15):2395-7. doi: 10.1517/14656560903176453.
3
Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?
Diabetes Obes Metab. 2009 May;11 Suppl 2:3-8. doi: 10.1111/j.1463-1326.2008.01031.x.
4
Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Metabolism. 2009 Aug;58(8):1059-66. doi: 10.1016/j.metabol.2009.03.007. Epub 2009 Jun 18.
5
Metformin: a biguanide.
Diabetes Educ. 1995 Nov-Dec;21(6):509-10, 513-4.
6
[Metformin role in the treatment of type 2 diabetes in 2008].
Rev Med Suisse. 2008 Jun 4;4(160):1392-4, 1396-7.
7
Metformin: fifty-two not out.
J Indian Med Assoc. 2009 Nov;107(11):779-84.
8
Glycaemic control in type 2 diabetes.
Clin Evid. 2005 Dec(14):474-90.
9
Metformin in the management of type 2 diabetes.
Diabet Med. 1989 Mar;6(2):179-80.
10
Metformin: 50 years old, fit as a fiddle, and indispensable for its pivotal role in type 2 diabetes management.
Diabetes Metab. 2006 Dec;32(6):555-6. doi: 10.1016/S1262-3636(07)70309-9.
Zotero 插件